A practical guide for providers on helping COPD patients locate Striverdi Respimat, manage access barriers, and explore alternatives when needed.
When a COPD patient calls your office saying they can't find Striverdi Respimat (Olodaterol) at the pharmacy, it's more than an inconvenience. Missing doses of a maintenance bronchodilator can lead to worsening symptoms, increased rescue inhaler use, and potentially avoidable exacerbations.
As a prescriber, you're uniquely positioned to help patients navigate access barriers — whether that means locating the medication, adjusting the prescription, or connecting them with financial assistance. This guide provides a practical, step-by-step approach to helping your patients stay on Striverdi or transition smoothly to an alternative.
Striverdi Respimat is not on the FDA's drug shortage list as of March 2026. Boehringer Ingelheim continues to manufacture it, and national supply is generally adequate. However, several factors reduce real-world availability at the pharmacy level:
For the full clinical picture, see our provider briefing: Striverdi shortage — what providers need to know in 2026.
When patients report difficulty finding Striverdi, the root cause typically falls into one of these categories:
The single most effective thing you can do is check the patient's formulary before writing the prescription. Most EHR systems and e-prescribing platforms offer real-time formulary lookups. If Striverdi isn't covered or requires prior authorization, you can:
Medfinder for Providers allows your staff to search for pharmacies near the patient's location that have Striverdi in stock. This is particularly useful for:
Patients can also use medfinder.com directly from home.
Independent pharmacies are often more willing to special-order specialty inhalers like Striverdi. They typically can have it available within 1-2 business days. Mail-order pharmacies connected to the patient's insurance plan may also offer more reliable access and potential cost savings on 90-day supplies.
Cost is a major barrier for patients, especially those without adequate insurance coverage. Make sure your team is aware of these programs:
Share our patient resource: How to save money on Striverdi in 2026.
If you know a specific pharmacy has Striverdi in stock (via Medfinder or patient feedback), send the prescription directly there. This avoids the frustration of patients arriving at a pharmacy only to learn the medication isn't available.
When Striverdi access is a persistent issue, therapeutic substitution may be the most practical path. Consider these options based on the patient's clinical needs:
For a patient-facing guide to alternatives, share: Alternatives to Striverdi.
Integrating medication access support into your workflow can prevent many issues before they reach the patient:
Helping patients access Striverdi Respimat requires a combination of clinical awareness, proactive communication, and knowledge of available resources. While the medication isn't officially in shortage, the practical barriers are real. By integrating tools like Medfinder for Providers into your workflow and connecting patients with financial assistance programs, you can reduce treatment gaps and improve outcomes for your COPD patients.
For the companion patient-facing article, share: How to find Striverdi in stock near you.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
